Clinical Trial Update: Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety of a topical antifungal treatment for tinea pedis, tinea cruris, and tinea corporis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Corporis
• Tinea Cruris
• Tinea Pedis

Drugs mentioned

• Topical antifungal treatment (unspecified)

Snippet

Sponsor: Tinea Pharmaceuticals | Conditions: Tinea Pedis, Tinea Cruris | Phase 3 | Status: COMPLETED